COPD 
The MD Magazine COPD condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Sponsored

CD4 Cell Count May Indicate COPD Risk in HIV-Positive Patients
Higher smoking rates in HIV-positive patients may contribute to COPD diagnoses.
Recently, researchers from the University of Colorado Anschutz Medical Campus discovered high doses of vitamin D helped older, long-term care residents reduce the risk of acute respiratory illness (ARI).
A study presented at CHEST 2016 in Los Angeles found that home visits made to non-compliant asthmatics or those with uncontrolled symptoms drastically increased their adherence to treatment and regular office visits in the following year.
A new study from Georgia State University examined the mechanisms by which resveratrol was able to work against Haemophilus influenzae, a major respiratory pathogen. The findings may be of use in developing non-antibiotic treatments for bacterial respiratory infections, and also for COPD and asthma therapies.
After 6 months of treatment with inhaled budesonide, 800 μg daily, bronchial hyperresponsiveness was greater and the proportion of eosinophils in induced sputum and improvement in lung function were lower in smokers than in nonsmokers with asthma.
Once-daily tiotropium added to inhaled corticosteroids was safe and well tolerated in a phase 3 trial in nearly 400 asthmatic adolescents.
There is no longer any question about the health risks associated with smoking. What remains to be found is what is the best way to help people who have started to smoke to quit.
As the effort continues to help people quit smoking research is being done to find the best treatment options available and any potential issues they may present in the process.
For patients who struggle with positive airway pressure machines there have been developments in recent years to help them treat their sleep apnea and other disorders.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$